Dr. Kristen Elizabeth Dunbar, MD

Dr. Dunbar practices at Prince William Ambulatory Surgery Center in Manassas, Virginia.

Dr. Dunbar's NPI, 1124384268, was assigned on April 3, 2012. Dr. Dunbar graduated from Emory University School of Medicine in 2012. Dr. Dunbar holds Virginia license 0101272336.

Dr. Dunbar's primary practice is Prince William Ambulatory Surgery Center, at 8644 Sudley Road, Suite 201, Manassas, VA 20110. The practice phone is (703) 369-8525.

Dr. Dunbar's primary practice is Prince William Ambulatory Surgery Center in Manassas, Virginia. Dr. Dunbar is also affiliated with UVA Health Prince William Medical Center. Dmand AI also links Dr. Dunbar to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dunbar practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Dunbar's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Dunbar is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Dunbar's licenses on file in 2 states: Virginia and New York.

CMS data shows 490 Medicare services from Dr. Dunbar across 10 procedure codes in 2024, for 234 Medicare patients. Medicare paid $59,726 for them.

CMS counts 234 Medicare patients who saw Dr. Dunbar in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dunbar's median patient age at 68, with 57% women.

In 2024, Dr. Dunbar wrote 204 Medicare Part D claims for 137 patients. 80% of them were for generic drugs. CMS names the drug for 175 of them, across 3 drugs with 11 or more claims each, at $1,667 in total drug cost. In 2023, CMS named 71 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Dunbar for performance year 2024, reported as part of a group. Dr. Dunbar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Dunbar, published from 2012 to 2018. 2017 was the busiest year, with 3. The most frequent topics are Ophthalmologic Surgical Procedures, Biopsy and Graves Ophthalmopathy. Dr. Dunbar has published most often in Ophthalmic Plast Reconstr Surg. Dr. Dunbar's most frequent co-authors are Michael Kazim, MD, Kyle J. Godfrey, MD and Stacy Marie Scofield-Kaplan, MD.

CMS Open Payments shows 41 general payments to Dr. Dunbar from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 51% of the total. Horizon Pharma plc paid the most, $1,391.

Dr. Dunbar graduated from Emory University School of Medicine in 2012.